The FDA said risks linked to CAR-T cell therapies can be effectively communicated through existing labeling, including boxed ...

Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a ...

Drug maker Shanghai Henlius traces its history to 1992, when four ambitious young entrepreneurs formed Fosun Group to seize ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Researchers at the University of Pennsylvania have turned a deadly fungus into a potent cancer-fighting compound after ...

A new medication found to reduce the chance of the most common types of breast cancer recurring will be available to many ...

For the first time in Australia, a drug that can delay the growth of tumours is available under the Pharmaceutical Benefits ...

Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

Pfizer insists that the discontinuation of the Phase II study was due to recruitment difficulties and was not linked to ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...